Home/Numedicus/David Cavalla
DC

David Cavalla

Founder and Key Scientific Leader

Numedicus

Numedicus Pipeline

DrugIndicationPhase
Glutamate Modulator for Rett SyndromeRett SyndromeLicensed/Orphan Designation
Espindolol (MT-102)Cancer CachexiaPhase 2/Spin-out
Exvastat ProgramSevere Covid-19Phase 2